Lunit, a leading provider of AI for cancer diagnostics and therapeutics, announced a collaboration with Microsoft to accelerate the delivery of AI-powered healthcare solutions....
SimonMed Imaging®, one of the largest and most advanced outpatient medical imaging providers in the United States, is proud to announce their partnership with Lunit,...
Robust preclinical pipeline of non-hallucinogenic neuroplastogens designed as potential best-in-class treatments for neuropsychiatric and neurodegenerative diseases
Transneural Therapeutics, Inc. (Transneural), a preclinical-stage biotechnology company aiming...
Asimov, the synthetic biology company advancing the design and production of therapeutics, announced the launch of the AAV Edge System, a comprehensive suite of...
Lunit's AI-powered biomarker, Lunit SCOPE PD-L1 TPS, integrates into Roche's navify® Digital Pathology platform to enhance precision medicine and improve cancer biomarker testing
Lunit, a leading...
Nimbus Therapeutics, LLC, a biotechnology company that designs and develops breakthrough medicines for patients through its powerful computational drug discovery engine, announced the appointment...
Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced the publication of a new study featuring Lunit SCOPE IO, Lunit's...